Screening for Substance Use in Rural Primary Care: a Qualitative Study of Providers and Patients.


Journal

Journal of general internal medicine
ISSN: 1525-1497
Titre abrégé: J Gen Intern Med
Pays: United States
ID NLM: 8605834

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 16 8 2019
medline: 28 11 2020
entrez: 16 8 2019
Statut: ppublish

Résumé

Substance use frequently goes undetected in primary care. Though barriers to implementing systematic screening for alcohol and drug use have been examined in urban settings, less is known about screening in rural primary care. To identify current screening practices, barriers, facilitators, and recommendations for the implementation of substance use screening in rural federally qualified health centers (FQHCs). As part of a multi-phase study implementing electronic health record-integrated screening, focus groups (n = 60: all stakeholder groups) and individual interviews (n = 10 primary care providers (PCPs)) were conducted. Three stakeholder groups (PCPs, medical assistants (MAs), and patients) at three rural FQHCs in Maine. Focus groups and interviews were recorded, transcribed, and content analyzed. Themes surrounding current substance use screening practices, barriers to screening, and recommendations for implementation were identified and organized by the Knowledge to Action (KTA) Framework. Identifying the problem: Stakeholders unanimously agreed that screening is important, and that universal screening is preferred to targeted approaches. Adapting to the local context: PCPs and MAs agreed that screening should be done annually. Views were mixed regarding the delivery of screening; patients preferred self-administered, tablet-based screening, while MAs and PCPs were divided between self-administered and face-to-face approaches. Assessing barriers: For patients, barriers to screening centered around a perceived lack of rapport with providers, which contributed to concerns about trust, judgment, and privacy. For PCPs and MAs, barriers included lack of comfort, training, and preparedness to address screening results and offer treatment. Though stakeholders agree on the importance of implementing universal screening, concerns about the patient-provider relationship, the consequences of disclosure, and privacy appear heightened by the rural context. Findings highlight that strong relationships with providers are critical for patients, while in-clinic resources and training are needed to increase provider comfort and preparedness to address substance use.

Sections du résumé

BACKGROUND
Substance use frequently goes undetected in primary care. Though barriers to implementing systematic screening for alcohol and drug use have been examined in urban settings, less is known about screening in rural primary care.
OBJECTIVE
To identify current screening practices, barriers, facilitators, and recommendations for the implementation of substance use screening in rural federally qualified health centers (FQHCs).
DESIGN
As part of a multi-phase study implementing electronic health record-integrated screening, focus groups (n = 60: all stakeholder groups) and individual interviews (n = 10 primary care providers (PCPs)) were conducted.
PARTICIPANTS
Three stakeholder groups (PCPs, medical assistants (MAs), and patients) at three rural FQHCs in Maine.
APPROACH
Focus groups and interviews were recorded, transcribed, and content analyzed. Themes surrounding current substance use screening practices, barriers to screening, and recommendations for implementation were identified and organized by the Knowledge to Action (KTA) Framework.
KEY RESULTS
Identifying the problem: Stakeholders unanimously agreed that screening is important, and that universal screening is preferred to targeted approaches. Adapting to the local context: PCPs and MAs agreed that screening should be done annually. Views were mixed regarding the delivery of screening; patients preferred self-administered, tablet-based screening, while MAs and PCPs were divided between self-administered and face-to-face approaches. Assessing barriers: For patients, barriers to screening centered around a perceived lack of rapport with providers, which contributed to concerns about trust, judgment, and privacy. For PCPs and MAs, barriers included lack of comfort, training, and preparedness to address screening results and offer treatment.
CONCLUSIONS
Though stakeholders agree on the importance of implementing universal screening, concerns about the patient-provider relationship, the consequences of disclosure, and privacy appear heightened by the rural context. Findings highlight that strong relationships with providers are critical for patients, while in-clinic resources and training are needed to increase provider comfort and preparedness to address substance use.

Identifiants

pubmed: 31414355
doi: 10.1007/s11606-019-05232-y
pii: 10.1007/s11606-019-05232-y
pmc: PMC6854168
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2824-2832

Subventions

Organisme : NIDA NIH HHS
ID : P30 DA029926
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA037202
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA040309
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA013035
Pays : United States

Références

Obstet Gynecol. 2012 May;119(5):1070-6
pubmed: 22525931
J Am Med Inform Assoc. 2012 May-Jun;19(3):392-400
pubmed: 22003156
Ann Epidemiol. 2018 Sep;28(9):641-652
pubmed: 29921551
Addiction. 2019 Mar;114(3):573-574
pubmed: 30397977
Healthc Exec. 2010 Mar-Apr;25(2):54, 56-7
pubmed: 20349764
Subst Use Misuse. 2014 Jun;49(7):891-901
pubmed: 24611820
Health Serv Res Manag Epidemiol. 2017 Oct 25;4:2333392817734523
pubmed: 29124080
J Behav Health Serv Res. 2004 Oct-Dec;31(4):418-29
pubmed: 15602142
Subst Abus. 2017 Oct-Dec;38(4):508-512
pubmed: 28762888
JAMA Intern Med. 2017 Oct 1;177(10):1480-1488
pubmed: 28846769
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Ann Intern Med. 2017 Feb 21;166(4):268-278
pubmed: 27919103
Psychiatr Serv. 2017 Sep 1;68(9):873-875
pubmed: 28806893
Subst Abus. 2016;37(1):20-4
pubmed: 26848803
J Am Board Fam Med. 2018 Mar-Apr;31(2):243-251
pubmed: 29535241
BMC Health Serv Res. 2018 Nov 14;18(1):857
pubmed: 30428882
J Rural Health. 2007 Fall;23 Suppl:79-83
pubmed: 18237329
J Rural Health. 2015 Summer;31(3):326-33
pubmed: 25953431
Community Ment Health J. 2005 Feb;41(1):21-33
pubmed: 15934173
Subst Abus. 2016 Oct-Dec;37(4):635-641
pubmed: 27164025
Med Clin North Am. 2015 Sep;99(5):989-1016
pubmed: 26320043
J Gen Intern Med. 2016 Feb;31(2):215-222
pubmed: 26269130
Ann Intern Med. 2016 Nov 15;165(10):690-699
pubmed: 27595276
J Addict Dis. 2008;27(3):77-97
pubmed: 18956531
Annu Rev Public Health. 2015 Mar 18;36:559-74
pubmed: 25581144
J Gen Intern Med. 2018 Mar;33(3):258-267
pubmed: 29086341
J Stud Alcohol. 2000 Mar;61(2):267-77
pubmed: 10757138
NCHS Data Brief. 2014 May;(151):1-8
pubmed: 24813076
JAMA Intern Med. 2017 Sep 1;177(9):1265-1272
pubmed: 28715535
Int Arch Med. 2009 May 05;2(1):14
pubmed: 19416533
BMC Med Inform Decis Mak. 2017 Apr 4;17(1):33
pubmed: 28376785
Drug Alcohol Depend. 2015 Apr 1;149:232-44
pubmed: 25735467
BMC Health Serv Res. 2013 Jul 08;13:261
pubmed: 23835062
J Rural Health. 2014 Summer;30(3):235-43
pubmed: 24528129
Health Aff (Millwood). 2014 May;33(5):770-7
pubmed: 24799573
J Interprof Care. 2006 Mar;20(2):105-18
pubmed: 16608714
Subst Abus. 2015;36(3):281-8
pubmed: 25127073
J Health Care Poor Underserved. 2014 Feb;25(1 Suppl):36-45
pubmed: 24583486
J Contin Educ Health Prof. 2006 Winter;26(1):13-24
pubmed: 16557505
Psychiatr Serv. 2019 May 1;70(5):409-412
pubmed: 30784378
JAMA. 2018 Nov 13;320(18):1899-1909
pubmed: 30422199
Pediatrics. 2016 Jul;138(1):
pubmed: 27325634
Addict Sci Clin Pract. 2018 Apr 9;13(1):8
pubmed: 29628018
Virtual Mentor. 2011 May 01;13(5):273-7
pubmed: 23131355

Auteurs

Elizabeth C Saunders (EC)

The Dartmouth Institute (TDI) for Health Policy and Clinical Practice, Lebanon, NH, USA. Elizabeth.C.Saunders.gr@dartmouth.edu.

Sarah K Moore (SK)

Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.

Trip Gardner (T)

Penobscot Community Health Care (PCHC), Bangor, ME, USA.

Sarah Farkas (S)

Department of Psychiatry, New York University School of Medicine, New York, NY, USA.

Lisa A Marsch (LA)

Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.

Bethany McLeman (B)

Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.

Andrea Meier (A)

Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.

Noah Nesin (N)

Penobscot Community Health Care (PCHC), Bangor, ME, USA.

John Rotrosen (J)

Department of Psychiatry, New York University School of Medicine, New York, NY, USA.

Olivia Walsh (O)

Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.

Jennifer McNeely (J)

Department of Population Health, New York University School of Medicine, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH